We are seeking one U.S.-based, privately-held Healthcare Services and Healthcare IT, Software & Technology company to acquire, operate, and grow for the long-haul that has an demonstrated history of profitability and growth. As entrepreneurs, we understand that every business is different, and very few businesses display all of these traits. But they are helpful in guiding our search.
Headquartered in Fremont, CA, Columbia Asthma & Allergy Clinic ("CAAC") is a leading regional provider of allergy, asthma, and immunology services that includes the comprehensive evaluation and treatment for adult and pediatric patients suffering from food allergy and allergy-related issues, such as asthma, hay fever, and hives.
Current portfolio company and currently pursuing growth initiatives through expanding clinic footprint (i.e., de novo), strategic acquisitions (i.e., add-ons), expanding service and product offerings, and operational growth initiatives.
Transaction Type and Overview:
Southern Alpha and Deerpath Capital Management, LP ("Deerpath") partnered with Columbia Asthma & Allergy Clinic founder, Dr. Sanjeev Jain, MD, PhD, to recapitalize the company. With the recapitalization of CAAC, Southern Alpha, Deerpath, and Dr. Jain formed Allergy Management Partners, LLC as an management service organization.
CAAC will continue to operate under its brand and will be led by Dr. Jain as President, while Allergy Management Partners will be led by Nicholas M. Browner as President & Chief Executive Officer (CEO) and Dr. Jain as Chief Operating Officer (COO) & Chief Medical Officer (CMO). The transaction provided liquidity to Dr. Jain , who remains a minority equity owner.